An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus
- PMID: 30010462
- PMCID: PMC6290921
- DOI: 10.1080/17425255.2018.1499726
An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus
Abstract
P-glycoprotein (P-gp)/ABCB1 and breast cancer resistance protein (BCRP)/ABCG2 are highly expressed in the placenta and fetus throughout gestation and can modulate exposure and toxicity of drugs and xenobiotics to the vulnerable fetus during the sensitive times of growth and development. We aim to provide an update on current knowledge on placental and fetal expressions of the two transporters in different species, and to provide insight on interpreting transporter expression and fetal exposure relative to the concept of fraction of drug transported. Areas covered: Comprehensive literature review through PubMed (primarily from July 2010 to February 2018) on P-gp and BCRP expression and function in the placenta and fetus of primarily human, mouse, rat, and guinea pig. Expert opinion: While there are many commonalities in the expression and function of P-gp and BCRP in the placenta and fetal tissues across species, there are distinct differences in expression levels and temporal changes. Further studies are needed to quantify protein abundance of these transporters and functionally assess their activities at various gestational stages. Combining the knowledge of interspecies differences and the concept of fraction of drug transported, we may better predict the magnitude of impact these transporters have on fetal drug exposure.
Keywords: ABC transporter; ABCB1; ABCG2; ATP-binding cassette transporter; BCRP; MDR1; P-glycoprotein; P-gp; breast cancer resistance protein; fetus; placenta; pregnancy.
Conflict of interest statement
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Figures
Similar articles
-
Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.J Cell Mol Med. 2018 Jul;22(7):3652-3660. doi: 10.1111/jcmm.13646. Epub 2018 Apr 24. J Cell Mol Med. 2018. PMID: 29691980 Free PMC article.
-
ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison.Expert Opin Drug Metab Toxicol. 2010 Nov;6(11):1385-98. doi: 10.1517/17425255.2010.514264. Epub 2010 Aug 26. Expert Opin Drug Metab Toxicol. 2010. PMID: 20738225 Review.
-
Chorioamnionitis Induces a Specific Signature of Placental ABC Transporters Associated with an Increase of miR-331-5p in the Human Preterm Placenta.Cell Physiol Biochem. 2018;45(2):591-604. doi: 10.1159/000487100. Epub 2018 Jan 29. Cell Physiol Biochem. 2018. PMID: 29402780 Free PMC article.
-
Maternal and Fetal Exposure to (-)-Δ9-tetrahydrocannabinol and Its Major Metabolites in Pregnant Mice Is Differentially Impacted by P-glycoprotein and Breast Cancer Resistance Protein.Drug Metab Dispos. 2023 Mar;51(3):269-275. doi: 10.1124/dmd.122.001110. Epub 2022 Nov 29. Drug Metab Dispos. 2023. PMID: 36446608 Free PMC article.
-
Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2).Drug Metab Pharmacokinet. 2012;27(1):85-105. doi: 10.2133/dmpk.dmpk-11-rv-098. Epub 2011 Nov 29. Drug Metab Pharmacokinet. 2012. PMID: 22123128 Review.
Cited by
-
Entry of cannabidiol into the fetal, postnatal and adult rat brain.Cell Tissue Res. 2024 Feb 17. doi: 10.1007/s00441-024-03867-w. Online ahead of print. Cell Tissue Res. 2024. PMID: 38366086
-
An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine.Pharmaceuticals (Basel). 2023 Oct 2;16(10):1397. doi: 10.3390/ph16101397. Pharmaceuticals (Basel). 2023. PMID: 37895868 Free PMC article. Review.
-
An update on placental drug transport and its relevance to fetal drug exposure.Med Rev (2021). 2022 Nov 21;2(5):501-511. doi: 10.1515/mr-2022-0025. eCollection 2022 Oct. Med Rev (2021). 2022. PMID: 37724167 Free PMC article. Review.
-
Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy.Int J Mol Sci. 2023 Aug 23;24(17):13089. doi: 10.3390/ijms241713089. Int J Mol Sci. 2023. PMID: 37685897 Free PMC article. Review.
-
Functionalized nanoparticles crossing the brain-blood barrier to target glioma cells.PeerJ. 2023 Jul 4;11:e15571. doi: 10.7717/peerj.15571. eCollection 2023. PeerJ. 2023. PMID: 37426416 Free PMC article.
References
-
-
Mao Q, Unadkat JD. Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update. AAPS J. 2015;17:65–82.
• Comprehensive review on BCRP
-
-
-
Wolking S, Schaeffeler E, Lerche H, et al. Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature. Clin. Pharmacokinet 2015;54:709–735.
• Comprehensive review on P-gp
-
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
